SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-075871
Filing Date
2023-09-12
Accepted
2023-09-12 07:30:35
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184690-6k_altamirather.htm   iXBRL 6-K 21049
2 UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS ea184690ex99-1_altamira.htm   iXBRL EX-99.1 360757
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea184690ex99-2_altamira.htm EX-99.2 161072
4 PRESS RELEASE DATED SEPTEMBER 12, 2023 ea184690ex99-3_altamira.htm EX-99.3 74313
  Complete submission text file 0001213900-23-075871.txt   3159878

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ears-20230630.xsd EX-101.SCH 53922
6 XBRL CALCULATION FILE ears-20230630_cal.xml EX-101.CAL 39794
7 XBRL DEFINITION FILE ears-20230630_def.xml EX-101.DEF 164062
8 XBRL LABEL FILE ears-20230630_lab.xml EX-101.LAB 364123
9 XBRL PRESENTATION FILE ears-20230630_pre.xml EX-101.PRE 172518
47 EXTRACTED XBRL INSTANCE DOCUMENT ea184690-6k_altamirather_htm.xml XML 269620
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 231249019
SIC: 2834 Pharmaceutical Preparations